Cupric Chloride Injection, Solution
Product Images NDC 72603-351

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cupric Chloride (NDC 72603-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Viallabel (Cl 351 01 00)

Viallabel (Cl 351 01 00)
This is a product label for a 10mL single-dose vial containing cupric chloride and sodium chloride, with specific dosages and osmolality provided. The vial is manufactured by Northstar Rx LLC and is intended for intravenous use only after dilution. The label also mentions the presence of aluminum in limited amounts. The product is manufactured by Immacule Lifesciences Private Limited in India. Lot and expiration information is also provided on the label.*
FDA Label Image

Cartonlabel (Ll 351 25 00)

Cartonlabel (Ll 351 25 00)
This text appears to be a detailed description of Cupric Chloride Injection, USP which is for intravenous use only after dilution. The injection contains cupric chloride and sodium chloride with specific concentrations. The product is sterile, non-pyrogenic, and manufactured for Northstar Healthcare Holdings Ltd. The usual dosage and storage instructions are provided on the label. Users are advised to follow the instructions for use, including dilution and cautious intravenous administration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.